z-logo
open-access-imgOpen Access
Principal component analysis of early immune cell dynamics during pembrolizumab treatment of advanced urothelial carcinoma
Author(s) -
Taro Teshima,
Yukari Kobayashi,
Taketo Kawai,
Yoshihiro Kushihara,
Koji Nagaoka,
Jimpei Miyakawa,
Yoshiyuki Akiyama,
Yuta Yamada,
Yusuke Sato,
Daisuke Yamada,
Nobuyuki Tanaka,
Tatsuhiko Tsunoda,
Haruki Kume,
Kazuhiro Kakimi
Publication year - 2022
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2022.13384
Subject(s) - pembrolizumab , urothelial carcinoma , oncology , cancer research , principal component analysis , medicine , cell cycle , carcinoma , cancer , immunotherapy , bladder cancer , computer science , artificial intelligence

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom